Flavopiridol
CAS: 146426-40-6
Ref. TM-T6837
5mg | 86,00 € | ||
10mg | 102,00 € | ||
25mg | 235,00 € | ||
50mg | 377,00 € | ||
1ml*10 (DMSO) | 92,00 € |
Informação sobre produto
- L868275, Alvocidib, NSC 649890 HCl, HMR-1275
- (-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4H-1-benzopyran-4-one
- 2-(2-Chlorophenyl)-5,7-Dihydroxy-8-[(3S,4R)-3-Hydroxy-1-Methyl-4-Piperidyl]Chromen-4-One
- 2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one
- 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methylpiperidin-4-yl]-4H-chromen-4-one
- 4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-, cis-(-)-
- 4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-
- Alvocidib
- Dsp 2033
- Flavopirodol
- Ver mais sinónimos
- Hl 275
- Hmr 1275
- L 86-8275
- L 868275
Flavopiridol (Alvocidib) (Alvocidib) competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM. It is 7.5-fold more selective for CDK1, 2, 4, 6 versus CDK7. Flavopiridol is initially found to inhibit EGFR and PKA. Phase 1/2.
Propriedades químicas
Consulta técnica sobre: TM-T6837 Flavopiridol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.